0001551259-17-000001.txt : 20170628 0001551259-17-000001.hdr.sgml : 20170628 20170628160320 ACCESSION NUMBER: 0001551259-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170628 DATE AS OF CHANGE: 20170628 EFFECTIVENESS DATE: 20170628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EMERGE DIAGNOSTICS, INC CENTRAL INDEX KEY: 0001551259 IRS NUMBER: 900849392 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-289636 FILM NUMBER: 17935230 BUSINESS ADDRESS: STREET 1: 5924 BALFOUR CT. STREET 2: SUITE 102 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 866-878-2597 MAIL ADDRESS: STREET 1: 5924 BALFOUR CT. STREET 2: SUITE 102 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: EMERGE DIAGNOSTICS, LLC DATE OF NAME CHANGE: 20140620 FORMER COMPANY: FORMER CONFORMED NAME: OKTX, LLC DATE OF NAME CHANGE: 20120531 D 1 primary_doc.xml X0707 D LIVE 0001551259 EMERGE DIAGNOSTICS, INC 5924 BALFOUR CT. SUITE 102 CARLSBAD CA CALIFORNIA 92008 866-878-2597 DELAWARE EMERGE DIAGNOSTICS, LLC OKTX, LLC Corporation true Robert Thompson 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Executive Officer Director Jerry Wilkins 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Executive Officer Director Mary Rose Reaston 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Executive Officer Phil Reaston 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Executive Officer Michael Connor 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Director Murray Lappe 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Director David Miller 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Director William Quirk 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Director Scott Wolesson 5924 Balfour Ct., Suite 102 Carlsbad CA CALIFORNIA 92008 Director Mark Sampson 11611 San Vicente Blvd Suite 1000 Los Angeles CA CALIFORNIA 90049 Director Other Health Care Decline to Disclose 06b false 2017-06-12 false true true true true false 0 8000000 250000 7750000 Tranche 1 consists of the sale of up to $7mm of newly issued Series E Preferred Stock; Tranche 2 consists of the purchase of up to $1mm of Series E Preferred Stock. false 1 0 0 0 false EMERGE DIAGNOSTICS, INC /s/ Robert D. Thompson Robert D. Thompson Chief Executive Officer 2017-06-28